Composition for improvement of cellular nutrition and mitochondrial energetics

Abstract

This invention provides a dietary supplement comprising L-Carnitine (or its functional analogues such as Acetyl-Carnitine or Proprionyl-1-Carnitine), Coenzyme Q10 and Taurine for the correction of the abnormality in mitochondrial energetics in cardiac failure and certain other diseases. A high protein nutritional feeding supplementation with Cysteine, Creatine, Vitamin E (RRR-d-alpha-tocopherol), Vitamin C (ascorbic acid), Selenium, and Thiamin in may be added.

We claim:  
     
         1 . A method of medical treatment of a disease, disorder or abnormal physical state in a mammal selected from the group consisting of heart disease and functional deterioration associated with ageing, the method comprising administering to a mammal an effective amount of a carrier and a nutritional supplement comprising L-Carnitine or its functional analogue, Coenzyme Q10 (Ubiquinone) or its functional analogue and Taurine or a Taurine precursor in a single or divided daily dose.  
     
     
         2 . The method of    claim 1   , wherein the method comprises administering to a mammal an effective amount of a carrier and a nutritional supplement comprising L-Carnitine, Coenzyme Q10 (Ubiquinone) and Taurine or a Taurine precursor in a single or divided daily dose.  
     
     
         3 . The method of    claim 1   , wherein the mammal is selected from the group consisting of humans, dogs, cats.  
     
     
         4 . The method of    claim 1   , wherein the disease, disorder or abnormal physical state comprises a disease, disorder or abnormal physical state that is due in whole or in part to aging.  
     
     
         5 . A method of increasing neuromuscular or athletic performance in a mammal, the method comprising administering to the mammal an effective amount of a carrier and a nutritional supplement comprising L-Carnitine or its functional analogue, Coenzyme Q10 (Ubiquinone) or its functional analogue and Taurine or a Taurine precursor in a single or divided daily dose.  
     
     
         6 . The method of    claim 5   , wherein the method comprises administering to the mammal an effective amount of a carrier and a nutritional supplement comprising L-Carnitine, Coenzyme Q10 (Ubiquinone) and Taurine or a Taurine precursor in a single or divided daily dose.  
     
     
         7 . The method of    claim 5   , wherein the mammal is selected from the group consisting of humans, dogs and cats.  
     
     
         8 . The method of    claim 7   , wherein the mammal is a human.